Ross Merkin

9PUBLICATIONS

48CO-AUTHORS

Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 10, 2026

Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.

|Jan 26, 2026

Who Benefits and When? Applying Circulating Tumor Human Papillomavirus DNA for Human Papillomavirus-Associated Oropharyngeal Carcinoma.

Ross D Merkin, Daniel L Faden, Lori J Wirth

|Jul 04, 2025

Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

Nikhil Dubey, Chia-Yun Wu, Leyre Zubiri

|May 20, 2025

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

Michael E Bryan, Ling Aye, Dipon Das

|Apr 20, 2025

Reversible downregulation of HLA class I in adenoid cystic carcinoma.

Annie Li, Bianca L Gonda, Elizabeth M Codd

|Apr 11, 2025

Outcomes for recurrent or metastatic head and neck cancer by HPV status: a systematic review and meta-analysis.

Jong Chul Park, Geun Hee Ye, Ross Merkin

Pageof 2

Frequent Collaborators

Lori Wirth

Daniel L Faden

Peter M Sadow

Jong Chul Park

Ling Aye

Yana Al-Inaya

Michael E Bryan

Shun Hirayama

Dipon Das

Thomas Roberts

Frequent Collaborators

Lori Wirth

Daniel L Faden

Peter M Sadow

Jong Chul Park